Get the Stockscreener App
572.28
1.14%
-6.62
After Hours:
572.28
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $572.28, with a volume of 1.58M.
It is down -1.14% in the last 24 hours and down -2.68% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$578.90
Open:
$577.85
24h Volume:
1.58M
Relative Volume:
0.78
Market Cap:
$215.01B
Revenue:
$43.74B
Net Income/Loss:
$6.58B
P/E Ratio:
33.07
EPS:
17.3072
Net Cash Flow:
$6.11B
1W Performance:
-0.09%
1M Performance:
-2.68%
6M Performance:
+37.79%
1Y Performance:
+9.01%
1-Day Range:
$570.19
$579.06
1-Week Range:
$561.91
$579.08
52-Week Range:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO) - Yahoo Finance
Citigroup Upgrades Thermo Fisher Scientific (TMO) - Nasdaq
Thermo Fisher launches X and S Series centrifuges with natural-refrigerant cooling - R&D World
Looking At Thermo Fisher Scientific's Recent Unusual Options Activity - Benzinga
Citi Upgrades Thermo Fisher Scientific (TMO) to Buy, Raises Pric - GuruFocus
Ex-Dividend Reminder: DT Midstream, HCA Healthcare and Thermo Fisher Scientific - Nasdaq
Thermo Fisher Scientific (TMO) valuation after fresh Wall Street upgrades and Asia bioprocessing expansion - simplywall.st
Thermo Fisher upgraded at Citi on boost in pharma spending - Seeking Alpha
Citigroup Upgrades Thermo Fisher Scientific (TMO), Raises Price Target | TMO Stock News - GuruFocus
Thermo Fisher Scientific expands its bioprocessing capabilities in Asia - European Pharmaceutical Review
Citigroup Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts PT to $660 From $580 - marketscreener.com
What Is Happening With Thermo Fisher Scientific Stock? - Trefis
Thermo Fisher Scientific on the value of an integrated approach to drug development - pharmaphorum
Is It Time To Reassess Thermo Fisher Scientific After Its Recent Share Price Pullback? - simplywall.st
Thermo Fisher Expands Bioprocessing in Asia - Powder & Bulk Solids
Is Thermo Fisher Still Attractively Priced After Recent Share Price Dip In 2025? - Yahoo Finance
Goldman Sachs Initiates Coverage of Thermo Fisher Scientific (TMO) with Buy Recommendation - Nasdaq
Thermo Fisher Expands Bioprocess Design Centers Across Asia - Lab Manager
Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs (A:NYSE) - Seeking Alpha
Q4 Earnings Estimate for TMO Issued By KeyCorp - MarketBeat
Natixis Has $23.43 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Ossiam Sells 3,400 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Acquired by London & Capital Asset Management Ltd - MarketBeat
Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TM - GuruFocus
6,343 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by SVB Wealth LLC - MarketBeat
Fluorosilicic Acid Market Size, Forecast 2031 by Key Companies- - openPR.com
Microplate Systems Market Is Booming So Rapidly| Thermo Fisher Scientific; Danaher Corporation; Agilent Technologies Inc; PerkinElmer Inc - pharmiweb.com
gRNA Market Size Worth USD 3,171.65 Million By 2034 Fueled by Rapid Expansion of Gene Editing Applications - GlobeNewswire Inc.
Axa S.A. Lowers Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating - Investing.com
Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating By Investing.com - Investing.com UK
Thermo Fisher Scientific introduces the Thermo Scientific X and S Series Centrifuges - SelectScience
TMO Stock Quote Price and Forecast - CNN
Keybanc Upgrades Thermo Fisher Scientific (TMO) - Nasdaq
Keybanc Upgrades Thermo Fisher Scientific (TMO) to 'Overweight' with Price Target of $750 | TMO Stock News - GuruFocus
Vega Investment Solutions Sells 11,414 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
WINTON GROUP Ltd Acquires Shares of 16,314 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Temasek Holdings Private Ltd Trims Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Stockbridge Partners LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
KeyBanc Upgrades Thermo Fisher Scientific to Overweight From Sector Weight, Price Target is $750 - marketscreener.com
Cerity Partners LLC Sells 2,142 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Baker Avenue Asset Management LP Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
KeyBanc upgrades Thermo Fisher Scientific stock rating to Overweight with $750 target - Investing.com India
Jump Financial LLC Purchases 38,298 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
California Public Employees Retirement System Decreases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cary Street Partners Financial LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brown Advisory Inc. Reduces Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Dnca Finance Has $8.49 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Bollard Group LLC Acquires 62,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Who Owns Thermo Fisher Scientific? Top Shareholders and Recent Insider Trades - TIKR.com
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.60%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):